Sources
Summarized by i88Tickers
Kessler Topaz Meltzer & Check, LLP announced it is investigating potential federal securities law violations by Madrigal Pharmaceuticals (NASDAQ: MDGL) on behalf of investors who suffered significant losses, according to a Nov. 6, 2026 release. The firm’s investigation follows Madrigal’s Nov. 3, 2026 disclosure in its quarterly report of a whistleblower complaint filed against the company. These developments come alongside separate investigations by Kaplan Fox & Kilsheimer LLP and the Law Offices of Frank R. Cruz, the latter examining disclosures about Madrigal on Nov. 5, 2026, and following an 8.1% stock decline.
Kessler Topaz Investigating Madrigal Pharmaceuticals on Behalf of Investors
Kessler Topaz Meltzer & Check, LLP announced it is investigating potential violations of the federal securities laws by Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) on behalf of investors who purchased or acquired Madrigal securities and experienced significant financial losses.
The Radnor, Pennsylvania-based firm, which describes itself as a nationally recognized securities litigation law firm, issued the announcement on November 6, 2026.
Whistleblower Complaint Disclosed
According to the announcement, Madrigal disclosed in its quarterly report on November 3, 2026, that a whistleblower complaint had been filed against the company.
The firm’s announcement references the disclosure in connection with its investigation but does not provide further detail on the nature of the complaint.
Investor Contact
Kessler Topaz states that investors who purchased or acquired Madrigal securities and suffered significant financial losses are encouraged to contact the firm. The announcement directs investors to the firm’s website, ktmc.com.
Other Firms Also Examining Madrigal
The Kessler Topaz investigation follows separate examinations of Madrigal by other firms:
- Kaplan Fox & Kilsheimer LLP has also opened an investigation, according to the source material.
- The Law Offices of Frank R. Cruz is examining disclosures about Madrigal made on November 5, 2026.
The developments come alongside an 8.1% decline in Madrigal’s stock, according to the source material.